Veterinary Medicine Information website

Nobilis RT+IBmulti+G+ND

Authorised
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bursal disease virus, strain D78, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis RT+IBmulti+G+ND
Active substance:
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bursal disease virus, strain D78, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken (chick)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Inactivated
    4.20
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain D78, Inactivated
    14.50
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    1.00
    Dose
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    1.00
    Dose
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5.50
    log2 virus neutralising unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Available in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2200
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 27/09/2023
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 27/09/2023
Download